A recurrent chalazion should be subjected to histopathologic evaluation to exclude the possibility of
**Core Concept**
A chalazion is a type of benign eyelid lesion resulting from the blockage of a meibomian gland, leading to inflammation and granulomatous reaction. However, in some cases, a recurrent chalazion may be a manifestation of an underlying systemic condition or malignancy.
**Why the Correct Answer is Right**
The primary concern in a recurrent chalazion is the possibility of basal cell carcinoma (BCC) or another form of skin malignancy. This is because a chalazion and a BCC can present similarly, and the recurrence of a chalazion-like lesion may indicate an underlying neoplastic process. Histopathological evaluation is essential to rule out malignancy, especially in cases of recurrent lesions.
**Why Each Wrong Option is Incorrect**
* **Option A:** While sebaceous gland carcinoma is a possibility in a recurrent chalazion, it is not the most common concern. Sebaceous gland carcinoma is a malignant tumor that arises from the meibomian or sebaceous glands, but it is less common than basal cell carcinoma.
* **Option B:** Squamous cell carcinoma is a type of skin cancer, but it is not typically associated with recurrent chalazions. Squamous cell carcinoma is more common in sun-exposed areas and is not usually confused with a chalazion.
* **Option D:** Sarcoidosis is a systemic granulomatous disease that can affect the eyelids, but it is not typically associated with recurrent chalazions. While sarcoidosis can cause granulomatous inflammation in the eyelids, it is less likely to present as a recurrent chalazion.
**Clinical Pearl / High-Yield Fact**
When evaluating a recurrent chalazion, it's essential to consider the possibility of underlying malignancy, especially basal cell carcinoma. A thorough histopathological evaluation is crucial to rule out malignancy and determine the correct treatment plan.
**Correct Answer:** C.